Toxin-antitoxin (TA) systems are small genetic elements of prokaryotes associated with persister cell formation, phage defence, stress regulation and programmed cell arrest. In this study, we characterized two paralogues of the ribosome-dependent RNase YefM-YoeB TA system from the Gram-positive organism Staphylococcus equorum SE3. 59 Rapid amplification of cDNA ends confirmed transcriptional activity in the exponential growth phase and revealed an extended 59 untranslated region upstream of the yefM-seq1 gene. Inducible expression of the putative yoeBseq1/2 toxins led to growth defects of Escherichia coli, which were counteracted by simultaneous induction of the cognate yefM-seq1/2 antitoxin candidates in a strictly pairwise manner. Bacterial two-hybrid assays revealed interaction between YoeB-seq1 and YefM-seq1 but not YoeB-seq1 and YefM-seq2, also indicating two independent systems. In vivo primer extensions demonstrated specific RNA cleavage adjacent to the start codons by YoeB-seq proteins, and YoeB-seq2 activity could be neutralized by the corresponding antitoxin YefM-seq2. Together, these results indicate that the two yefM-yoeB-seq1/2 paralogues from S. equorum encode functional TA systems.
INTRODUCTION
Toxin-antitoxin (TA) systems are small and frequently bicistronic genetic elements that are found over a broad phylogenetic range of prokaryotic organisms. They commonly consist of an RNA or a protein antitoxin which inactivates a toxic protein under default conditions. Fluctuations in gene expression or degradation of the antitoxin unleash the toxin to interfere with critical cellular functions such as translation, replication, generation of proton motive force or cell-wall synthesis (reviewed by Yamaguchi et al., 2011) . Depending on the nature and the mode of action of the antitoxin, five types of TA systems have been classified (reviewed by . Suggested or verified roles of TA systems include plasmid and mobile genetic element stabilization, protective responses to adverse conditions, growth control, phage defence, formation of drug-tolerant persister cells and programmed cell death or cell arrest (Magnuson, 2007) . Besides a type I TA system regulated by a small RNA (Sayed et al., 2012a, b) , three type II TA loci have so far been described in the Gram-positive opportunistic pathogen Staphylococcus aureus, namely one MazEF sa system and two YefM-YoeB-sa paralogues (Fu et al., 2007; Yoshizumi et al., 2009) . In contrast to the RNA antitoxin in type I TA systems, type II TA systems employ an antitoxin protein that inactivates the toxin protein by direct interaction. The toxins YoeB-sa1 and YoeB-sa2 cleave mRNA adjacent to start codons, whereas two related RNA sequence motifs of four or five nucleotides each have been proposed as MazF sa -specific restriction sites (Fu et al., 2007; Zhu et al., 2009) . The cleavage of virulence-factor gene transcripts by MazF sa had raised speculations about its role in posttranscriptional control of pathogenicity (Zhu et al., 2009) , but the recent discovery of a functional orthologue in the non-pathogenic Staphylococcus equorum suggests additional roles of staphylococcal MazEF TA systems . S. equorum, which was described by Schleifer et al. (1984) , is relevant in the food industry as a starter culture for cheese and as a producer of an anti-listerial compound (Carnio et al., 2000; Place et al., 2003) . At least two sequencing projects of the S. equorum genome have been started (Irlinger et al., 2012 and R. Rosenstein, personal communication) and in silico screens have previously identified at least ten putative TA loci in the strain SE3 . These include one mazEF and two yefM-yoeB paralogues, reflecting the currently known set of validated type II TA systems found throughout different S. aureus strains. Following our previous analysis of the MazEF seq system, we here describe the characterization of the YefMYoeB-seq paralogues of S. equorum SE3 to investigate parallels and/or differences compared with the S. aureus counterparts across a broader phylogenetic scope of staphylococci. 59 Rapid amplification of cDNA ends (59 RACE) promoter mappings of the yefM-yoeB systems in both S. equorum and S. aureus revealed transcriptional activity in the exponential growth phase, similar but not identical promoter sequences and a significantly extended 59 untranslated region (UTR) in the case of yefM-seq1. Heterologous expression in Escherichia coli demonstrated that toxicity of YoeB-seq1 and YoeB-seq2 can specifically and strictly pairwise be abolished by the antitoxins YefM-seq1 and YefM-seq2, respectively. Accordingly, bacterial adenylate cyclase two-hybrid (BACTH) assays revealed specific in vivo protein-protein interactions between the toxin YoeBseq1 and its cognate antitoxin YefM-seq1. In vivo cleavage of ompA mRNA in E. coli close to the start codon indicated ribosome-dependent endoribonuclease activity of both YoeBseq proteins. These results are highly indicative that the two paralogous yefM-yoeB-seq systems from S. equorum are functional TA systems.
METHODS
Fine chemicals, oligonucleotides and enzymes. Chemicals were bought from Carl Roth, Sigma-Aldrich and Merck at the highest purities available. Enzymes for DNA restriction, modification and cloning as well as DNA size markers were purchased from New England Biolabs and Fermentas/Thermo Scientific. The DNA polymerases Taq and Reprofast were obtained from Genaxxon. Kit systems for plasmid preparation, PCR purification and gel extraction were purchased from Qiagen. For 59 RACE and in vivo primer extension analysis, Ambion SUPERase-In, Ambion diethylpyrocarbonate (DEPC)-treated double distilled H 2 O, Ambion THE RNA storage solution and the TOPO TA Cloning kit for sequencing with One Shot chemically competent T10 E. coli cells were used (Life Technologies). Roti-Aqua-P/C/I (phenol/chloroform/isoamyl alcohol, 25 : 24 : 1, pH 4.5-5) was acquired from Carl Roth, T4 RNA ligase from New England Biolabs, tobacco acid pyrophosphatase from Epicentre/Illumina and avian myeloblastosis virus reverse transcriptase (AMV RT) and the first-strand cDNA synthesis kit for RT-PCR from Roche. The Thermo Sequenase Fluorescent Labelled Primer Cycle sequencing kit with 7-deaza-dGTP was obtained from GE Healthcare. Lysostaphin was acquired from Dr Petry Genmedics. Synthetic DNA and RNA oligonucleotides (listed in Table 1) were ordered from Biomers.
Bacterial strains, plasmids and growth conditions. A list of Escherichia and Staphylococcus strains and plasmids used in this study can be found in Table 2 . All liquid cultures were grown at 37 uC and 150 r.p.m. in 100 ml baffled glass flasks unless stated otherwise. Staphylococcus cells were cultivated in BM medium [1 % (w/v) soy peptone, 0.5 % (w/v) yeast extract, 0.5 % (w/v) NaCl, 0.1 % (w/v) K 2 HPO 4 . 3H 2 O, 0.1 % (w/v) glucose], whereas E. coli cells were cultivated in BM or lysogeny broth (LB) (corresponding to BM without K 2 HPO 4 and glucose) medium for general cloning. To ensure tight repression of the pBAD system (used to induce yoeB-seq genes), M9 medium (Smith & Levine, 1964) [0.6 % (w/v) Na 2 HPO 4 , 0.3 % (w/v) KH 2 PO 4 , 0.1 % (w/v) NH 4 Cl, 0.05 % (w/v) NaCl, 1 mM MgSO 4 , 2 mg thiamine l 21 , 0.2 % (w/v) Casamino acids] supplemented with either 0.4 % (w/v) glucose or 0.2 % (v/v) glycerol was used. Cells harbouring pBAD33 or plasmids derived thereof were cultivated with 25 mg chloramphenicol ml
21
, pET-21c(+), pUT18 and pUT18C with 100 mg ampicillin ml 21 , and pKT25 and pKNT25 with 50 mg kanamycin ml 21 .
Molecular cloning and isolation of nucleic acids. Genes of interest were PCR amplified from S. equorum SE3 genomic DNA, cloned using standard protocols and the resulting constructs were used to transform E. coli DH5a or XL1blue cells. Positive clones were identified by colony PCR and the constructs were assessed by analytical restriction and/or sequencing (GATC Biotech). Chemically competent E. coli cells were prepared using RbCl treatment as described by Hanahan (1983) . Bacterial genomic DNA was isolated by a protocol derived from Marmur (1961) . In brief, cells from a 50 ml overnight culture grown in BM were harvested by centrifugation (4600 g, 10 min) and then resuspended in 10 ml P1 buffer (50 mM Tris/HCl, pH 8.0, 10 mM EDTA, 100 mg RNase A ml 21 ). Staphylococcal cells but not E. coli were disintegrated by lysostaphin until slimy. The cell suspensions were then treated with 500 ml saturated SDS [in 45 % (v/v) ethanol] and 3.3 ml 5 M NaClO 4 . Genomic DNA was extracted with 15 ml chloroform/isopentanol (24 : 1 ratio) by vigorous shaking and subsequent centrifugation (10 min, 4600 g) and the DNA in the aqueous phase was precipitated in 100 % ethanol, withdrawn by glass hooks (modified Pasteur pipettes), washed in 70 % (v/v) ethanol, dried at room temperature and taken up in double distilled H 2 O.
For RNA preparation, cells were broken in a tissue lyser (Thermo Savant; FastPrep FP120 Bio 101) with glass beads twice for 20 s at 6.5 m s 21 and extracted by Trizol treatment according to the manufacturer's protocol. Precipitated RNA was taken up in THE RNA storage solution (Ambion). Samples for primer extensions were subsequently treated with 20 U RNase-free DNase I per 100 mg, phenol/chloroform extracted and resuspended in 30 ml DEPC-treated H 2 O (Ambion).
Construction of heterologous expression plasmids and growth analysis of E. coli. The assumed toxin genes yoeB-seq1 and yoeBseq2 were PCR amplified from S. equorum SE3 genomic DNA using primer pairs yoeB-seq1_f and yoeB-seq1_r, or yoeB-seq2_f and yoeBseq2_r, respectively, and cloned into the pBAD33 vectors using the restriction enzymes XmaI and SalI. Likewise, the putative antitoxin genes yefM-seq1 and yefM-seq2 were cloned into the pET-21c(+) vectors via NdeI and BamHI using primer pairs yefM-seq1_f and yefM-seq1_r, or yefM-seq2_f and yefM-seq2_r.
E. coli cells harbouring single plasmids or plasmid combinations were grown overnight in M9 glycerol medium with the appropriate antibiotics and inoculated to an OD 578 of 0.07 into medium of the same composition. Growth was followed by optical density measurements (Hitachi spectrometer U-2900) at 578 nm on an hourly basis. At indicated time points, arabinose (0.1 %, w/v) and/or IPTG (0.1 mM) was added to induce toxin and/or antitoxin expression.
For solid media tests, the same strains were streaked out on antibiotic-supplemented M9 agar plates containing glycerol. Plates also contained arabinose (0.2 %, w/v) and/or IPTG (0.05 mM) as indicated and were incubated overnight at 37 uC.
BACTH analysis of toxin and antitoxin components. Plasmid construction and BACTH studies were done as described previously using primer pairs yoeB-seq1_bacth_f and yoeB-seq1_bacth_r and BACTH_yefM2se_f and BACTH_yefM2se_r and the restriction enzymes BamHI and XmaI. In brief, genes of interest were cloned as translational fusions either N-terminally (plasmids pUT18, pKNT25) or C-terminally (pUT18C, pKT25) to the Bordetella pertussis cyaA fragments T18 or T25. Interaction of the bait and prey protein leads to an assembly of the T18 and T25 fragments and yields active adenylate cyclase. This results in high cAMP levels and thus activation of the lactose utilization genes, assayed by blue colorization of colonies on X-Gal-containing media. Suspected toxin genes were cloned into the low copy vectors pKT25/pKNT25 to reduce toxicity of the encoded YoeB-seq proteins. Indeed, the N-and C-terminal yoeB-seq1 fusion constructs from our previous study led to a slight growth inhibition, noticeable by the smaller colony size. yoeB-seq2 BACTH plasmids free of mutations could not be obtained, arguably due to strong toxicity of this protein.
Construction of yefM-seq1 and yefM-seq2 BACTH plasmids was unproblematic.
The resulting plasmids were used to transform E. coli BTH101 cells (cya 2 ), yielding strains containing different combinations of one T18 and T25 fragment construct each. Obtained colonies were resuspended in 1 % saline solution and 10 ml drops pipetted on LB Km50/ Amp100 plates further supplemented with X-Gal (40 mg ml
) and IPTG (0.5 mM). Plates were incubated for 24 h at 30 uC and stored at 4 uC to enhance coloration, indicating protein-protein interaction.
Determination of transcription start sites by 5 § RACE. 59 RACE experiments to detect transcription start sites of the yefM-yoeB-seq1/2 systems were done as previously described . Briefly, 7.5 mg of RNA prepared from S. aureus HG003 or S. equorum SE3 cells grown to mid-exponential phase (OD 578 of 1.4) in BM medium was treated with tobacco acid pyrophosphatase (Epicentre), ligated to an RNA adaptor fragment and reverse transcribed using the first-strand cDNA synthesis kit for RT-PCR (Roche) with primers specific to the respective yefM genes. PCR products of obtained cDNA were cloned into a TOPO TA vector (Life Technologies) and plasmids isolated from clonal cultures were sequenced (GATC Biotech).
Analysis of YoeB-seq proteins' RNA cleavage preference by in vivo primer extensions. E. coli BW25113 or BL21(DE3) cells carrying different plasmids for suspected toxin and/or antitoxin expression were grown overnight in M9 medium with glucose and inoculated the next morning in 50 ml M9 medium with glycerol in 250 ml baffled flasks. After reaching an OD 578 of 0.8, cells were induced with arabinose (0.1 or 0.2 %, w/v) and/or IPTG (0.1 mM) as indicated (see Fig. 4 below) and harvested after 30 min incubation. RNA was then isolated and prepared for in vivo primer extensions, carried out as described before . Briefly, 10-15 mg RNA was incubated with 2 pmol of a DY-681-labelled ompA primer (IRD700_OmpA_ec) in a volume of 5 ml for 1 min at 95 uC and 5 min on ice. Reverse transcription of the RNA was conducted with 16 AMV RT buffer, 4 U Superase-In, 10 U AMV RT (Roche) and 10 nmol dNTPs at 47 uC in a reaction volume of 10 ml. The reaction was stopped after 60 min by heating to 95 uC for 2 min and adding 6 ml stop solution [95 % formamide (v/v), 10 mM EDTA, 0.05 % bromophenol blue (w/v)] to the reaction. Sequencing reactions were conducted from genomic DNA using the Thermo Sequenase fluorescently labelled primer cycle sequencing kit with 7-deaza-dGTP (GE Healthcare) and analysed on a Li-Cor Long ReadIR 4200 system using the IRD700 channel according to the manufacturer's protocol. 
RESULTS AND DISCUSSION
Promoters of yefM-yoeB loci from S. equorum and S. aureus are similar but not identical
In our previous study, we had identified two paralogous yefM-yoeB loci in the S. equorum SE3 genome by in silico analysis . Both systems had shown similar genetic organizations (Fig. 1a) and high protein primary structure similarities to their S. aureus orthologues yefM-yoeB-sa1 and yefM-yoeB-sa2 . Activity profiling had previously revealed transcription of both S. aureus yefM-yoeB systems in the exponential growth phase (Donegan & Cheung, 2009 ), but the location of respective promoters and transcriptional starting points (TSPs) had not been reported. We therefore performed 59 RACE experiments directed against all four yefM-yoeB systems from exponentially grown S. aureus and S. equorum cells (Fig. 1b) . Apparent 210 elements of s A -dependent promoters were especially conserved upstream of yefM-seq2 and yefM-sa2, containing no mismatches to the consensus sequence TATAAT and only one identical exchange in the promoters of both yefM-1 systems (TACAAT). The 235 regions were slightly more degenerated, containing one to three exchanges compared with the TTGACA consensus sequence. In all cases, a spacer of 17 bp was found between the 210 and 235 hexamers. The TSPs were located 6-7 nt downstream from the deduced (Serganov & Nudler, 2013) and one might hypothesize that the 59 UTR of yefM-seq1 might fulfil a similar function. These results are in agreement with the expression of yefM-yoeB-sa systems in exponential growth phase cells (Donegan & Cheung, 2009 ) and confirm the activity of the respective S. equorum counterpart promoters under the same conditions. Due to a lack of genetic amenability of S. equorum SE3, in vivo characterization of the yefM-yoeB-seq loci in the native context is not feasible at present. However, we noted possible regulatory sequences in the 210 site and adjacent regions. The yefMseq1 system contains 11 bp direct repeats downstream of the 210 region and another one partially overlapping with positions of the RBS. The yefM-sa1 locus contains a 27 bp palindromic sequence with a 7 bp spacer upstream of the 235 region that might be involved in transcriptional control. Indeed, palindromes enclosing the 235 region of the orthologous yefM-yoeB Spn locus in Streptococcus pneumoniae apparently confer transcriptional autoregulation (Chan et al., 2011) . Interestingly, the yefM-yoeB-sa2 system is flanked by unique 70 bp perfect direct repeats, and it is tempting to speculate on a role in recombination. Future studies may clarify the roles of these cis elements. We next examined if the genes of these putative TA systems have toxic and antitoxic effects.
Growth inhibition of yoeB-seq expression in E. coli can be alleviated by cognate yefM-seq induction
To elucidate if expression of yoeB-seq inhibits growth, E. coli BL21(DE3) cells were equipped with various combinations of yoeB-seq and yefM-seq genes under the control of mutually independent inducible promoters. For this, arabinose-inducible pBAD33 plasmids containing a synthetic RBS and either the putative toxin gene yoeB-seq1 or yoeB-seq2 and pET-21c(+) plasmids, sensitive to IPTG control, carrying either antitoxin candidate yefM-seq1 or yefM-seq2 were constructed. The plasmids pBAD33 and pET-21c(+) are compatible due to distinct origins of replication and antibiotic markers. 
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YefM-YoeB toxin-antitoxin systems in S. equorum
Cells carrying different combinations of empty or yoeB-seqcontaining pBAD33 plasmids and empty or yefM-seqcontaining pET-21c(+) plasmids (Fig. 2) were streaked out on solid M9 media containing either no inducers, arabinose, IPTG or both substances. As expected, cells lacking yoeB-seq alleles did not show any growth defect under any conditions tested, regardless of the insert of the pET-21c(+) vector (Fig. 2a, b, sectors 1 and 3) . Cells bearing the pBAD33 yoeB-seq1 or 2 expression plasmids and the empty pET-21c(+) vector were inhibited in growth by arabinose due to induction of the putative toxin (Fig. 2a, b, sector 2) . However, when the suspect cognate antitoxin was present on the pET-21c(+) vector, the cells showed a growth defect only with arabinose but not on media containing both arabinose and IPTG (Fig. 2a, b , sector 4). In this case, the simultaneous expression of yefMseq left growth unaffected. Antitoxin candidates of paralogous systems were incapable of cross-inhibiting YoeB-seq (Fig. 2c ), in accordance with results observed with their S. aureus counterparts (Yoshizumi et al., 2009) . The toxin as well as the antitoxin protein paralogues of S. equorum SE3 differ significantly among each other in their sequences (50 % identity, 66 % similarity and 30 % identity, 45 % similarity, respectively; Fig. 1c) . Presumably, the paralogous systems were independently acquired or gene duplication happened so long ago that the systems functionally detached in the course of evolution.
To corroborate these results, cells carrying either the yefMyoeB-seq1 or the -seq2 constructs were inoculated to an initial OD 578 of 0.07 in M9 glycerol media and the growth was monitored by optical density measurements. Noninduced cells grew normally and cultures entered the early stationary phase after about 6 h and reached an OD 578 plateau of about 3 (Fig. 3, dotted lines) . Induction of only yoeB-seq1 or yoeB-seq2 led to a severe growth inhibition (Fig.  3, solid lines, filled triangles) , indicating a toxic effect of the YoeB-seq proteins. Interestingly, the growth impediment imposed by yoeB-seq2 was more strongly pronounced compared with that of yoeB-seq1 expression (OD 578 7 h post-induction of~0.5 vs. 1.0) although both plasmids contained the same synthetic RBS. These results suggest that YoeB-seq2 is more toxic than YoeB-seq1. In fact, this hypothesis is further supported by the observation that yoeB-seq2 was more prone to mutations during cloning, presumably due to a higher selective pressure for inactive alleles (our unpublished observations). In line with the solid media experiments, concurrent expression of yefM-seq1 with yoeB-seq1 prevented toxicity (Fig. 3a) , resulting in growth patterns comparable with the uninduced control and indicating inactivation of YoeB-seq1 by YefM-seq1. Likewise, YefM-seq2 alleviated toxicity of YoeB-seq2 (Fig. 3b) , although OD 578 values did not reach those of the uninduced control, but levelled off between yoeB-seq2-induced and uninduced cells. Together, these growth tests indicate that the expression of both yoeB-seq paralogues is toxic for E. coli cells and that simultaneous expression of the cognate yefM genes can antagonize this effect; we thus henceforth refer to YoeB-seq as toxins and YefM-seq as antitoxins.
To investigate if yoeB-seq-dependent growth-arrested E. coli cells can restart to proliferate by delayed induction of the cognate antitoxin, growth-rescue experiments were conducted (Fig. 4) . Again, E. coli BL21(DE3) cells carrying pBAD33 yoeB-seq1 and pET-21c(+) yefM-seq1 were inoculated in liquid media to an initial OD 578 of 0.07 and the toxin yoeB-seq1 induced by the addition of arabinose after 2 h (Fig. 4, black arrow) . The antitoxin yefM-seq1 was IPTG-induced either simultaneously, or 1, 2, 3, 4, 5 or 7 h after yoeB-seq1 induction. As demonstrated before (Fig. 3a) , cells that simultaneously started expression of yoeB-seq1 and yefM-seq1 were not inhibited in growth compared with the non-induced control (Fig. 4) . Notably, also 1 or 2 h delayed activation of yefM-seq1 initiated regrowth, which started in our setup 2 and 5 h, respectively, after antitoxin induction. Induction of the antitoxin 3, 4, 5 or 7 h after induction of the toxin did not lead to a detectable resuscitation of the cells (Fig. S1 , available in Microbiology Online).
Interestingly, cells that were only expressing yoeB-seq1 without the addition of antitoxin inducer also reassumed growth after 10 h from inoculation. This makes it difficult to determine if a 'point of no return' exists, as proposed for E. coli mazF (Amitai et al., 2004) . We assume that this phenomenon can be attributed to using a plasmid inducible system. One can hypothesize that single cells will stochastically develop loss-of-function mutations in genes of toxin-expression plasmids and thereby gain a selective growth advantage which becomes noticeable only after prolonged incubation times. Nevertheless, these experiments clearly demonstrate that YoeB-seq1 intoxicated cells can be rescued also by time-delayed yefM-seq1 induction, an observation that is especially interesting in the light of the endoribonuclease toxin mechanism (see Conclusions). -Ara/-IPTG +Ara/-IPTG +Ara/+IPTG simultaneously +Ara/+IPTG 1 h later +Ara/+IPTG 2 h later 6 7 8 9 10 11 Time (h) Fig. 4 . Growth-rescue experiment with E. coli BL21(DE3) cultures. Cells carrying pBAD33 yoeB-seq1 and pET-21c(+) yefM-seq1 were treated with inducers for toxin (0.1 % arabinose) after 2 h and/ or antitoxin (0.1 mM IPTG) at the time points indicated by arrows.
YoeB-YefM-seq components specifically interact in vivo
In most cases, toxin and antitoxin components of type II TA systems undergo protein-protein interactions to inhibit the activity of the toxin. We therefore subjected the YoeBseq and YefM-seq proteins to an in vivo BACTH assay (Karimova et al., 1998) .
The positive control (eukaryotic leucine zipper proteins fused to adenylate cyclase fragments T25 and T18, Fig. 5,  panel 1C) showed distinct blue colorization on X-Gal/ IPTG plates, as expected for protein-protein interactions, whereas a number of negative controls gave rise to yellow colonies. These included empty T18 or T25 fragment plasmids (panel 1A), MazE seq (an antitoxin of the MazEF seq system; in combination with YoeBseq1 (panels 5A-D) and toxin MazF seq with YefM-seq1 (panels 2A and 3A). Cells containing the BACTH constructs with yoeB-seq1 and yefM-seq1 together (panels 2B, 2C, 3B and 3C) grew to blue colonies. This interaction further supports the hypothesis of yefM-yoeB-seq1 encoding a bona fide type II TA system.
We also tested for possible cross-interactions between the YoeB-seq1 and the YefM-seq2 proteins of the two paralogous systems. As shown in Fig. 5 (panels 4A-D) , the BACTH assay does not suggest protein-protein interactions in this case. We therefore conclude that the YefM-seq antitoxins are unable to inhibit their paralogous, non-cognate YoeB-seq counterparts.
YoeB-seq proteins cleave mRNA adjacent to the start codon The S. aureus toxins YoeB-sa1 and YoeB-sa2 are endoribonucleases that cleave mRNA in proximity to the start codon , and orthologues from other Gram-positive species behave similarly (Halvorsen et al., 2011; Sevillano et al., 2012) . Intuitively, this suggests ribosome-dependent cleavage to prevent translation as in the case of the E. coli YoeB ). In the reported study, the cleavage activity depends on the association to the 50S ribosomal subunit.
To elucidate if this also held true for the S. equorum YoeBseq1 and 2 toxins, we conducted in vivo primer extensions. To this end, E. coli BW25113 cells carrying either yoeB-seq1 or yoeB-seq2 on the plasmid pBAD33 were cultivated in M9 media with 0.2 % glycerol until mid-exponential phase (OD 578 of 0.8) after which toxin expression was induced by the addition of 0.2 % arabinose for 30 min. Total RNA was isolated and primer extensions against the E. coli ompA transcript were conducted to determine the cleavage site(s) in the mRNA by the YoeB-seq1 and 2 toxins. ompA mRNA has proven useful as a target for staphylococcal YoeB before . The respective RNA isolated from cells carrying the empty pBAD33 vector, or the uninduced pBAD33 vector with yoeB-seq1, was not cleaved in proximity to the start codon, but minor bands upstream thereof were visible, probably attributed to RNA secondary structures (Fig. 6a) . Induction of yoeB-seq1, however, led to a strong signal (black filled arrowhead) shortly downstream Fig. 5 . Interaction studies of YoeB-seq1 with YefM-seq1 and YefM-seq2. BACTH analysis of YefM-seq1 and 2 with YoeBseq1 in E. coli BTH101. Open reading frames of interest were translationally fused with adenylate cyclase fragment T18 (Nterminal: pUT18, C-terminal: pUT18C) or T25 (N-terminal: pKNT25, C-terminal: pKT25). The table lists strains and plasmids (pUT18 and pUT18C abbreviated as pUT, pKT25 and pKNT25 as pKT) used. R (reaction) column indicates if X-Gal reaction was positive (+) or negative ("). Blue coloration, indicative of in vivo protein-protein interaction, was observed with YefM-seq1 and YoeB-seq1 (panels 2B, 2C, 3B and 3C), whereas the antitoxin of the yefM-yoeB-seq2 system did not show interaction with the toxin from the yefM-yoeB-seq1 system (panels 4A-D). Positive and negative controls displayed expected results.
of the ATG start codon, one fainter band several bases downstream of the first site (non-filled arrowhead with dotted line) and several much weaker bands (grey shaded arrows). This banding pattern is identical to that found for the S. aureus orthologue YoeB-sa1 and suggests the same cleavage mechanism for both homologues. RNA restriction obviously occurred directly downstream of the start codon and therefore supports the hypothesis that the YoeB-seq toxins in S. equorum are also ribosome-dependent endoribonucleases.
In the case of the pBAD33 yoeB-seq2 construct, also a clear cleavage signal immediately downstream of the start codon at the same position as in the yoeB-seq1 construct was apparent (Fig. 6a, black filled arrowhead) . In addition, three extra signals a few bases downstream of the main cleavage site were present: one weaker band (open arrowhead with dotted line), identical to the results from yoeB-seq1 expression experiment, one more intense band (open arrowhead with solid line) and one weak band (grey arrow), all specific to yoeB-seq2 expression. Intriguingly, distinct bands were repeatedly visible also with the uninduced control. When compared with the induced pBAD33 yoeB-seq2 construct, the banding patterns look identical but weaker in the uninduced control. In addition, the restriction patterns also match the results from Yoshizumi et al. (2009) . As demonstrated before, YoeB-seq1 toxicity was less severe than that of YoeB-seq2 in liquid growth experiments and also cloning procedures hint towards an elevated activity of YoeB-seq2 compared with the YoeB-seq1 paralogue. This could explain why basal expression of yoeB-seq2 caused RNA restriction, whereas the yoeB-seq1 construct only led to cleavage when induced. With the aim to demonstrate complete abolition of residual cleavage by non-induced YoeB-seq2, primer extensions were also conducted with RNA from E. coli BL21(DE3) cells carrying pBAD33 yoeB-seq2 and pET21c(+) yefM-seq2. The leaky expression of both toxin and antitoxin at the same time should then be sufficient to prevent activity of YoeB-seq2. Indeed, the ompA mRNA of the non-induced as well as of the antitoxin-induced cells was intact around the start codon (Fig. 6b) , confirming that incomplete repression of yoeB-seq2 had caused the cleavage in the first experiment (Fig. 6a) and that this effect could be impeded by the cognate antitoxin. Expression of yoeB-seq2 also did not result in RNA cleavage if the antitoxin yefM-seq2 was induced 10 min before the toxin. Presumably during this short period of time a sufficient amount of antitoxin molecules is produced to later scavenge the bulk of toxins. When yoeB-seq2 and yefMseq2 are simultaneously induced, weak cleavage becomes visible, indicating that not all toxin molecules are inhibited by antitoxins. Sole induction of yoeB-seq2 leads to a strong Fig. 6 . In vivo primer extensions for yoeB-seq1 and yoeB-seq2 in E. coli. The complement of an ompA sequencing ladder is depicted on the left-hand side and cleavage sites are marked by filled arrowheads (main cleavage), open solid or dotted arrowheads (intermediate cleavage) and grey arrows (weak cleavage) (a) E. coli BW25113 cells carrying pBAD33 WT (empty) or pBAD33 with yoeB-seq1 or yoeB-seq2 were subjected to 0.2 % arabinose for 30 min after reaching an OD 578 of 0.8 and in vivo primer extensions from total RNA were done. (b) E. coli BL21(DE3) (pBAD33 yoeB-seq2, pET-21c(+) yefM-seq2) cells were induced simultaneously with 0.1 mM IPTG (antitoxin) and/or 0.1 % arabinose (toxin) as indicated and in vivo primer extension experiments from total RNA were conducted. In one sample, the toxin yoeB-seq2 was induced for only 20 min, after a 10 min yefM-seq2 antitoxin pre-induction (marked by an asterisk).
cleavage pattern comparable to that in the first experiment and is also considerably stronger than in the simultaneously induced yoeB-seq2/yefM-seq2 strains. Abolition of YoeB-seq2 endoribonuclease activity by concomitant expression of yefM-seq2 in vivo corresponds to the observations of the growth experiments, where the toxicity of yoeB-seq2 was diminished by the induction of the cognate antitoxin yefM-seq2. In summary, our in vivo primer extensions showed identical cleavage patterns for both YoeB-seq toxins as their S. aureus orthologues ), indicating the same or similar cleavage mechanisms.
However, it remains to be determined how the two minor cleavage sites are caused, as they are not directly adjacent to the start codon, only cleaved in the presence of the YoeB toxins and the banding pattern between the paralogous systems differ. It is conceivable that the observed differences in toxicity of YoeB-seq1 and YoeB-seq2 are reflected by RNA cleavage specificity and activity.
CONCLUSIONS
In the present study, several lines of evidence unambiguously suggest that yefM-yoeB-seq1 and -seq2 loci encode functional TA systems, in accordance with their S. aureus counterparts. Unfortunately, homologous expression of proteins in S. equorum SE3 is not feasible, as this organism is as yet not transformable and as such in vivo studies in this organism are confined. However, the transcriptional start sites of both the S. equorum and the S. aureus yefMyoeB loci could be determined experimentally, which for the first time to our knowledge allowed explicit mapping of the promoters of staphylococcal yefM-yoeB TA genes. It will be interesting to decipher putative regulatory roles of the particularly extended 59 UTR of the yefM-seq1 transcript identified here. Expression of yoeB-seq1 and yoeB-seq2 proved to be toxic for E. coli cells and the cognate antitoxins were able to alleviate this effect, as expected for canonical type II TA systems. Strikingly, even delayed induction of the antitoxin yefM-seq1 impeded YoeB-seq1 toxicity, suggesting that also longer periods of YoeB-seq1 activity are not detrimental to cells.
Cleavage downstream of and close to the start codon of the tested mRNA suggests that YoeB-seq proteins act as ribosome-dependent RNases and in this regard the rescue of yoeB-intoxicated and growth-stalled cells by antitoxin induction even after an hour-long delay is remarkable. If prolonged activation of yoeB-seq led to cleavage of all ribosome-associated mRNAs one would suspect that the cell would at a certain point reach a state where all cellular functions (mainly translation) are severely impaired, after which the cell is inevitably moribund. Thus, YoeB-seqstressed cells might still retain the ability to produce proteins, as at least part of the translation machinery remains intact, a phenomenon also observable for other TA systems (Suzuki et al., 2005) .
It would be interesting to elucidate which kinds of RNA are the natural substrates of the YoeB proteins in their native contexts. Another open question is which roles these small genetic elements play in their host and under which conditions they are active. Chromosomal yefM/yoeB systems from S. aureus appear to be transcriptionally induced by subinhibitory levels of certain antibiotics (Donegan & Cheung, 2009 ). In our previous in silico screening , yefM/yoeB-seq1 was found to be located on a chromosomal contig (.2.7 mbp), whereas the yefM/yoeB-seq2 might be located on a small extrachromosomal element (,25 kbp, unpublished data, R. Rosenstein, personal communication, sequencing and assembling in progress). If it indeed becomes evident that the genetic localization between both systems differs, then their physiological roles might vary significantly. The closely related axe-txe TA system from an enterococcal resistance plasmid acts as a plasmid-stabilizing element (Grady & Hayes, 2003) and further instances of these TA systems were identified on several resistance plasmids (Moritz & Hergenrother, 2007) . In the face of these results, it seems plausible that the yefM/yoeB-seq2 system might be involved in maintenance of one of the putatively many plasmids found in S. equorum strain SE3. This hypothesis could also explain the difference in YoeB-seq toxicity between the orthologues, as the possible plasmid maintenance system 2 might be optimized towards irreversibly harming the cell to promote its distribution, whereas the chromosomal system 1 might exert a role in stress regulation to dampen physiological activity for a confined period of time. Regardless, the roles of the yefM-yoeB TA systems in staphylococci remain elusive and further work could give exciting insight into their contribution to staphylococcal physiology.
